相关实验视频
Updated: Jan 17, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
19.0K
药物不服药对不良结果的影响:通过生存分析从精神分裂症患者获得的证据
Shahriar Noroozizadeh1, Pim Welle2,1, Jeremy C Weiss3
1Carnegie Mellon University, USA.
Proceedings of machine learning research
|September 22, 2025
概括
在精神分裂症患者中,不坚持抗精神病药物显著提升了不良结果,包括早期死亡和住院治疗,为14个月. 保持药物坚持对于延迟精神病危机至关重要.
科学领域:
- 精神病学和心理健康 精神病学和心理健康
- 生物统计学和流行病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 精神分裂症治疗的坚持是一个重大挑战.
- 对抗精神病药物的不坚持与患者的不良结果有关.
- 量化不服药对不良事件的确切影响对于临床和政策决策至关重要.
研究的目的:
- 量化抗精神病药物不服药与精神分裂症不良结果之间的关联.
- 应用和扩展因果推理方法与生存分析相结合,以估计药物坚持的治疗效应.
- 分析在不同纵向数据周期 (3-12个月) 上的坚持的影响.
主要方法:
- 使用生存分析来建模发生不良事件的时间 (早期死亡,非自愿住院,监狱预订).
- 扩展的因果推断技术 (T-学习者,S-学习者,最近邻居匹配) 适应了生存模型.
- 分析是使用来自宾夕法尼亚州阿勒盖尼县的纵向数据进行的,有和没有县提供的风险得分.
主要成果:
- 不坚持服用抗精神病药物与大约1至4个月的不良结果的推进有关.
- 废除研究表明,县级风险得分因关键混因素而调整,因为它们的去除放大了估计的影响.
- 亚组分析始终显示与先前的不良事件相关的不遵守,无论药物配方 (注射或口服) 或类型.
结论:
- 对精神分裂症患者来说,药物坚持在延迟精神病危机方面发挥着至关重要的作用.
- 将生存分析与因果推断相结合,为药物坚持提供了与政策相关的见解.
- 虽然应用了因果推断方法,但结果是关联性的,强调需要仔细解释因果论断的假设.
相关概念视频
01:28Drug Therapy
245
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
245
01:26Psychosis: Goals of Pharmacotherapy
476
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
476
01:20Comparing the Survival Analysis of Two or More Groups
561
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
561
01:29Psychological and Sociocultural Causes of Schizophrenia
481
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
481
01:15Assumptions of Survival Analysis
398
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
398
01:28Psychosis and Antipsychotic Drugs: Overview
817
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
817